SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is based in Rolle, Switzerland.

SOPHiA GENETICS SA

BTIG analyst Mark Massaro reiterated a Buy rating on SOPHiA GENETICS yesterday and set a price target of $7.00. According to TipRanks, Massaro is a...

BTIG Sticks to Their Buy Rating for SOPHiA GENETICS (SOPH)

SOPHiA GENETICS ( ($SOPH) ) just unveiled an update. On November 4, 2025, SOPHiA GENETICS SA released its unaudited interim condensed consolidated ...

SOPHiA GENETICS Reports Financial Results for Q3 2025

Craig-Hallum analyst William Bonello maintained a Buy rating on SOPHiA GENETICS today. The company’s shares opened today at $5.26. According to Tip...

Craig-Hallum Keeps Their Buy Rating on SOPHiA GENETICS (SOPH)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on SOPHiA GENETICS (SOPH – Research Report) and Sanofi ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	SOPH	$4.54	+16.71%	264.65K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	SOPH	$4.54	+16.7%	264.65K
3
4
5
6

SOPH

SOPH

Get SOPHiA GENETICS SA Data in Excel

Get SOPHiA GENETICS SA Data in Excel